P
Ping Li
Researcher at GlaxoSmithKline
Publications - 34
Citations - 894
Ping Li is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: AS03 & Vaccination. The author has an hindex of 16, co-authored 34 publications receiving 818 citations.
Papers
More filters
Journal ArticleDOI
Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.
Sylvia Taylor,Pio Lopez,Lily Yin Weckx,Charissa Borja-Tabora,Rolando Ulloa-Gutierrez,Eduardo Lazcano-Ponce,Angkool Kerdpanich,Miguel Angel Rodriguez Weber,Abiel Mascareñas de los Santos,Juan Carlos Tinoco,Marco Aurélio Palazzi Sáfadi,Fong Seng Lim,Marcela Hernandez-de Mezerville,Idis Faingezicht,Aurelio Cruz-Valdez,Yang Feng,Ping Li,Serge Durviaux,Gerco Haars,Sumita Roy-Ghanta,David W. Vaughn,Terry Nolan +21 more
TL;DR: Active surveillance of healthy children provided evidence of respiratory illness burden associated with several viruses, with a substantial burden in older children.
Journal ArticleDOI
Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
Joanne M. Langley,Louise Frenette,Linda Ferguson,Dennis Riff,Eric Sheldon,George Risi,Casey Johnson,Ping Li,Richard Kenney,Bruce L. Innis,Louis Fries +10 more
TL;DR: The AS03-adjuvanted A/Indonesia/05/2005 (NIBRG-14) vaccines were significantly more immunogenic than nonadjuVanted vaccine in homologous assays and fulfilled European and US licensure criteria for immunogenicity for influenza vaccines.
Journal ArticleDOI
Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
Joanne M. Langley,George Risi,Michael Caldwell,Larry Gilderman,Bruce Berwald,Charles Fogarty,Terry Poling,Dennis Riff,Mira Baron,Louise Frenette,Eric Sheldon,Harry Collins,Marc Shepard,Marc Dionne,Daniel Brune,Linda Ferguson,David W. Vaughn,Ping Li,Louis Fries +18 more
TL;DR: In adults and elderly adults, AS03A-adjuvanted H5N1 candidate vaccine was highly immunogenic for A/Indonesia/05/2005, with cross-reactivity against A/Vietnam/1194/2004.
Journal ArticleDOI
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.
TL;DR: In adult recipients, Tdap3v was comparable to an approved TdAP vaccine in providing seroprotection against diphtheria and tetanus, and produced immune responses to pertussis antigens consistent with protection against disease.
Journal ArticleDOI
Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant
Murdo Ferguson,George Risi,Matthew Davis,Eric Sheldon,Mira Baron,Ping Li,Miguel Madariaga,Louis Fries,Olivier Godeaux,David W. Vaughn +9 more
TL;DR: A single dose of the 3.75-μg HA AS03(A)-adjuvanted H1N1 2009 influenza vaccine was highly immunogenic in both age strata (18-64 and >64 years), inducing long-term persistence of the immune response until at least 6 months after dose 1.